3. Electronic Theses and Dissertations (ETDs) - All submissions
Permanent URI for this communityhttps://wiredspace.wits.ac.za/handle/10539/45
Browse
2 results
Search Results
Item Preformulation and formulation study of dexchlorphenniramine maleate for use in the development of a new sustained release dosage form(1994-03) Fabian, JunePreformulation and formulation study of dexchlor- pheniramine maleate (DCPM) for it's inclusion into a gelforming sustained release dosage form was investigated. A modification of the USP apparatus 2 is proposed as an alternative to currently recommended USP dissolution apparatus for floating, gelforming drug delivery systems. In addition, the role of magnesium stearate and talc as dissolution retardants in controlled release matrix tablets is investigated, through application of a factorial design.Item Viability of high performance liquid chromatography as a method of mycobacterial identification in South African laboratories(2001) Naidoo, ShironaPathogenic mycobacterial infection was in recent decades a health concern so well controlled that eradication seemed imminent. However, it is once again reaching epidemic proportions following the increasing prevalence of AIDS. One important means of curbing this resurgence, is a robust method that has the capability of identifying to a species level speciating disease causing mycobacteria in a matter of days. Several new methodologies are now available that enable dramatic reductions in turn-around times. In this study High Performance Liquid Chromatography was investigated to determine how this system compared with the current mycobacterial system of methodologies adopted in South African laboratories. Four species of pathogenic mycobacteria, with a high prevalence in South Africa, were tested in a sample size of 80. Samples were subjected to HPLC, Gene Probes and Biochemical testing. HPLC was the most capable of identifying the mycobacteria to species level displaying a sensitivity to the organisms of 96.25 %. Gene probes and Biochemical testing had sensitivity values of 82.5 % and 80 % respectively. HPLC was also more cost efficient and displayed a wider range of identification. It is therefore suggested that HPLC replace Gene probes and Biochemical testing for purposes of MOTT identification in the comprehensive mycobacterial identification system. The result is a time saving of at least 3 weeks and a cost reduction of approximately 30 %. The large initial capital investment required for the implementation of the HPLC system is justified by the long term cost saving as well as the additional utility derived from early identification. As a consequence treatment is not empiric but rather tailored to the organism infecting the patient, hence preventing multiple drug resistance developing and ultimately saving a life through rational drug use.